JAAD Review Flags Kaposi Sarcoma as Emerging JAK Inhibitor Signal
A JAAD systematic review published online October 17, 2026 consolidates case reports of Kaposi sarcoma emerging during Janus kinase inhibitor therapy, framing it as a safety signal.
Topic
Drug Safety
Topic
Drug Safety
Isotretinoin Psychiatric Risk Under Study in Transgender Patients
A new study probes psychiatric risk of isotretinoin in transgender patients, a cohort long absent from acne-therapy safety data.…
Large French Cohort Finds Low Infection Risk With Psoriasis Biologics
A large French cohort reported low overall infection risk with psoriasis biologics, per AJMC. The headline signals directional re…
Pregnancy Registry Data Offer Reassurance on Dupilumab Safety
A pregnancy registry reports reassuring findings on dupilumab exposure, giving dermatologists a concrete data point for counselin…
Kaposi's Sarcoma Case Raises Questions for OX40/OX40L in AD
A Frontiers article asks whether Kaposi's sarcoma signals the end of OX40/OX40L targeting in atopic dermatitis, raising tumor-saf…
Cureus Review Compares Long-Term JAK Inhibitor Safety Across Derm and Rheum
A Cureus narrative review compares long-term cardiovascular, thromboembolic and malignancy safety of JAK inhibitors in dermatolog…
Liver Function Test Elevations Rare With Biologics in Psoriasis and HS
Liver function test elevations occur rarely in psoriasis and HS patients on biologics, Dermatology Times reports — supporting str…
GLP-1 Users Report Onycholysis at Four Times the Rate of Nonusers
An EADV 2026 survey of 1,904 patients found 39% of GLP-1 users reported nail detachment versus 9% of nonusers, with gaps persisti…
Hydrochlorothiazide Use Linked to Elevated Skin Cancer Risk
Medscape reports hydrochlorothiazide may raise skin cancer risk through photosensitization, urging closer screening and sun-prote…
Plaintiff Attorneys Vie for Leadership Roles in Dupixent MDL Over Cancer Claims
Attorneys are competing for leadership posts in the Dupixent MDL, where plaintiffs allege Sanofi and Regeneron failed to warn abo…